Abstract:OBJECTIVE The authors previously demonstrated that Cerebrolysin is effective for treatment of mild closed head injury (CHI) when administered 4 hours after injury. The aim of this study was to determine Cerebrolysin’s effects on functional and histological outcomes in rats subjected to moderate CHI. METHODS In this randomized, blinded, and vehicle-controlled preclinical trial, male adult Wistar rats subjected to moderate CHI received either Cerebrolysin treatment at a dose of 2.5 ml/kg (n = 13) or vehicle (saline, n = 13) intraperitoneally administered daily for 10 days, starting at 4 hours after injury. Animals were subjected to cognitive and sensorimotor functional tests at multiple time points, and they were killed 3 months after injury. The brains were processed for analyses of neuronal cell loss, amyloid precursor protein, axonal damage, and neurogenesis. RESULTS Compared with rats treated with vehicle (saline), rats treated with Cerebrolysin had significantly increased numbers of neuroblasts and newborn mature neurons in the dentate gyrus (DG) and attenuated amyloid precursor protein accumulation and axonal damage in various brain regions, as well as decreased neuronal loss in the DG and cornu ammonis 3 (CA3) region of the hippocampus (p < 0.05). Global testing using generalized estimating equations showed a significant beneficial effect of Cerebrolysin treatment on sensorimotor functional outcomes from 1 day to 3 months after injury compared to that of saline treatment (p < 0.05). Compared with vehicle-treated rats, Cerebrolysin-treated rats showed significantly and robustly improved long-term (up to 3 months) cognitive functional recovery, as measured by social interaction, Morris water maze, novel object recognition, and odor recognition tests. In the Cerebrolysin-treated rats there were significant correlations between multiple histological outcomes and functional recovery evident 3 months after moderate CHI, as indicated by Pearson partial correlation analyses. CONCLUSIONS The authors’ findings demonstrate that Cerebrolysin treatment significantly improves long-term functional and histological outcomes in rats with moderate CHI, with functional outcomes significantly correlated with histological indices of neuroplasticity and neuroprotection. These data indicate that Cerebrolysin may be useful for the treatment of moderate CHI.

Cerebrolysin Reduces Amyloid-Β Deposits, Apoptosis and Autophagy in the Thalamus and Improves Functional Recovery after Cortical Infarction.

Reduction of β-amyloid deposits by γ-secretase inhibitor is associated with the attenuation of secondary damage in the ipsilateral thalamus and sensory functional improvement after focal cortical infarction in hypertensive rats.

Cerebrolysin enhances functional recovery following focal cerebral infarction in rats

Attenuation of Secondary Damage and Aβ Deposits in the Ipsilateral Thalamus of Dmcao Rats Through Reduction of Cathepsin B by Bis(propyl)-Cognitin, a Multifunctional Dimer.

Beclin 1 Knockdown Inhibits Autophagic Activation and Prevents the Secondary Neurodegenerative Damage in the Ipsilateral Thalamus Following Focal Cerebral Infarction

The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.

Randomized controlled trial of Cerebrolysin’s effects on long-term histological outcomes and functional recovery in rats with moderate closed head injury

Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway

Abstract TP103: Liraglutide Reduces Amyloid-β Deposits and Secondary Damage in the Thalamus after Focal Cortical Infarction in Rats

Liraglutide Ameliorates Β-Amyloid Deposits and Secondary Damage in the Ipsilateral Thalamus and Sensory Deficits after Focal Cerebral Infarction in Rats

Memantine Ameliorates Tau Protein Deposition and Secondary Damage in the Ipsilateral Thalamus and Sensory Decline Following Focal Cortical Infarction in Rats

Efficacy of Cerebrolysin on Patients with Acute Cerebral Infarction

Enhanced Angiogenesis in the Thalamus Induced by a Novel TSPO Ligand Ameliorates Cognitive Deficits after Focal Cortical Infarction.

Ebselen Reduces Autophagic Activation and Cell Death in the Ipsilateral Thalamus Following Focal Cerebral Infarction

2-Cl-mgv-1 Ameliorates Apoptosis in the Thalamus and Hippocampus and Cognitive Deficits after Cortical Infarct in Rats.

Cerebroside-A Provides Potent Neuroprotection After Cerebral Ischaemia Through Reducing Glutamate Release And Ca2+ Influx Of Nmda Receptors

Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors.

Attenuation of Early Brain Injury and Learning Deficits Following Experimental Subarachnoid Hemorrhage Secondary to Cystatin C: Possible Involvement of the Autophagy Pathway

Systemic Analysis of the Efficacy and Safety of Cerebrolysin in the Treatment of Alzheimer's Disease

Neuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats.

Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer’s disease